The invention relates to novel anilide compounds represented by the following formula IV: n n n as that formula is further defined herein. n The inventive compounds are useful in the form of a pharmaceutical composition, specifically as an acyl coenzyme A cholesterol acyltransferase (ACAT) inhibitor.